The Impact of Prior Antithrombotic Status on Cerebral Infarction in Patients with Atrial Fibrillation

Background Anticoagulation effectively prevents cardioembolic stroke in atrial fibrillation (AF) patients, whereas it is less effective than antiplatelet therapy (AT) in noncardioembolic stroke prevention. We hypothesized that the ischemic lesion pattern and vascular patency would differ according t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of stroke and cerebrovascular diseases 2014-09, Vol.23 (8), p.2054-2059
Hauptverfasser:	Kim, Bum Joon, MD, Kim, Hyo Jin, MD, Do, Youngrok, MD, Lee, Ju-Hun, MD, Park, Kwang-Yeol, MD, Cha, Jae-Kwan, MD, Kim, Hahn-Young, MD, Kwon, Jee-Hyun, MD, Lee, Kyung Bok, MD, Kim, Dong-Eog, MD, Ha, Sang-Won, MD, Sohn, Sung-Il, MD, Kwon, Sun U., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - therapeutic use Anticoagulation atrial fibrillation Atrial Fibrillation - complications Cardiovascular Cerebral Infarction - drug therapy Cerebral Infarction - etiology Cerebral Infarction - pathology Female Humans International Normalized Ratio - standards Male Middle Aged Neurology Platelet Aggregation Inhibitors - therapeutic use prognosis Registries - statistics & numerical data Retrospective Studies Risk Factors stroke mechanism Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!